 | • レポートコード：MRC2203A589 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界の吸収性組織用スペーサー市場規模が予測期間中に年平均約4.9％成長すると予測しています。本調査資料では、吸収性組織用スペーサーの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（ヒドロゲルベーススペーサー、生分解性バルーンスペーサー）分析、用途別（放射線治療、感染管理）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の吸収性組織用スペーサー市場規模：製品別（ヒドロゲルベーススペーサー、生分解性バルーンスペーサー） ・世界の吸収性組織用スペーサー市場規模：用途別（放射線治療、感染管理） ・世界の吸収性組織用スペーサー市場規模：エンドユーザー別（病院、外来手術センター、その他） ・世界の吸収性組織用スペーサー市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Biocomposites、Bioprotect Ltd.、Boston Scientific、BD (CR Bard)、Palette Life Sciences） ・市場機会・将来の傾向 |
The Absorbable Tissue Spacer market studied is anticipated to grow with a CAGR of nearly 4.9%, during the forecast period. Certain factors that are driving the market growth include increasing prevalence of cancer and advantages associated with tissue spacer.
Globally, cancer is one of the leading causes of death. The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period. The World Health Organization (WHO) estimates the rate of cancer number to increase to 70% over the next two decades.
Additionally, the increased burden of several lifestyle disorders is also expected to drive the market, as biomarkers play a vital role in risk assessment, early diagnosis, and effective monitoring of treatment.
Key Market Trends
Hydrogel-based Spacers Hold Significant Share in the Global Absorbable Tissue Spacer Market
- Hydrogel based tissue spacers have usage across many fields of cancer. Prostate-rectum hydrogel spacer application is a relatively safe technical procedure that is well tolerated and has a high technical success rate. Spacer application significantly reduces rectal radiation dose and results in long-term reductions in rectal toxicity, as well as improvements in bowel, urinary, and sexual quality of life.
- Various recent clinical trial results have demonstrated that the prostate-rectum spacer application technique is safe and well tolerated, and that the space created significantly reduces rectal injury during radiation therapy, leading to long-term clinical benefits. A clinically significant reduction in radiation therapy complication rates leads to improved patient outcomes, reduced toxicity concerns, and hopefully overall cost reductions.
North America Dominates the Global Absorbable Tissue Spacer Market
As per the American Cancer Society, in 2018, the United States witnessed around 164,690 new cases of prostate cancer, causing over 26,430 deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. In order to tackle such challenges, extensive research in the field of diagnostics has been undertaken.
The ease in the US government regulations and availability of funds from various organizations, like the National Institute of Health, has provided the potential for researchers to invest more in developing absorbable tissue spacers. Hence, owing to the aforementioned factors, the entire region is expected to hold the major share in the global absorbable tissue spacer market.
Competitive Landscape
The global Absorbable Tissue Spacer market is competitive and consists of a few major players. Companies like Biocomposites, Bioprotect Ltd., Boston Scientific, CR Bard, Palette Life Sciences., among others, hold a substantial market share in the market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Cancer
4.2.2 Advantages associated with Tissue Spacer
4.3 Market Restraints
4.3.1 High Cost and Lack of Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Hydrogel Based Spacers
5.1.2 Biodegradable Balloon Spacers
5.2 By Application
5.2.1 Radiotherapy
5.2.2 Infection Management
5.3 By End-User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Biocomposites
6.1.2 Bioprotect Ltd.
6.1.3 Boston Scientific
6.1.4 BD (CR Bard)
6.1.5 Palette Life Sciences
7 MARKET OPPORTUNITIES AND FUTURE TRENDS